Aridis Pharma Says Phase 2a Study Of AR-501 In Cystic Fibrosis Meets Endpoints

RTTNews | 715 days ago
Aridis Pharma Says Phase 2a Study Of AR-501 In Cystic Fibrosis Meets Endpoints

(RTTNews) - Aridis Pharmaceuticals, Inc. (ARDS) announced Monday preliminary top-line results from the randomized, double blinded, placebo-controlled Phase 2a study of AR-501, which evaluated the safety and pharmacokinetics of three ascending doses of AR-501 administered as an inhaled aerosol in cystic fibrosis (CF) patients with confirmed Pseudomonas aeruginosa bacterial and other potential infections.

The study was conducted with funding support from the Cystic Fibrosis Foundation. AR-501 is being developed as a once-per-week inhaled dosing regimen that is self-administered using a commercially available nebulizer device.

The study's primary and secondary endpoints of safety and pharmacokinetics (PK) were met. Three weekly inhaled doses of AR-501 at 6.4mg, 20mg, and 40mg dose levels were also well tolerated in CF patients. Inhaled delivery achieved more than 10-fold higher respiratory uptake of gallium (AR-501) than past clinical studies of intravenous (IV) gallium.

For More Such Health News, visit rttnews.com

read more
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Wednesday, following the mixed cues from Wall Street overnight, as data showing a deterioration in U.S. consumer confidence in February fueled bets on US Fed interest rate cuts this year. Worries about the potential impact of imminent tariffs by Trump administration on global economic growth limited the market's upside.
RTTNews | 7h 10min ago
Australian Market Maintains Early Losses In Mid-market

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintaining its early losses in mid-market trading on Wednesday, extending the losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,300 level, with weakness across most sectors led by mining amid tumbling metal prices.
RTTNews | 7h 31min ago
Thai Shares May Take Further Damage On Wednesday

Thai Shares May Take Further Damage On Wednesday

The Thai stock market has finished lower in two straight sessions, tumbling almost 40 points or 3.2 percent in that span. The Stock Exchange of Thailand now sits just above the 1,205-point plateau and it may extend its losses on Wednesday.
RTTNews | 8h 36min ago
Oversold Indonesia Bourse Called Lower Again On Wednesday

Oversold Indonesia Bourse Called Lower Again On Wednesday

The Indonesia stock market has finished lower in back-to-back sessions, retreating more than 215 points or 3.2 percent along the way. The Jakarta Composite Index now sits just beneath the 6,590-point plateau and it's expected to see continued consolidation again on Wednesday.
RTTNews | 9h 6min ago
Japanese Market Significantly Lower

Japanese Market Significantly Lower

The Japanese stock market is trading significantly lower on Wednesday, adding to the losses in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling below the 37,900 level, with weakness across most sectors led by index heavyweights and financial stocks.
RTTNews | 9h 15min ago
More Pain Predicted For Hong Kong Stock Market

More Pain Predicted For Hong Kong Stock Market

The Hong Kong stock market has finished lower in consecutive trading days, slumping almost 450 points or 2 percent along the way. The Hang Seng Index now sits just above the 23,030-point plateau and it's looking at another soft start again on Wednesday.
RTTNews | 9h 21min ago
Australian Market Slightly Higher

Australian Market Slightly Higher

Australian stock market is trading modestly lower on Wednesday, extending the losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,300 level, with weakness across most sectors led by mining and technology stocks.
RTTNews | 9h 33min ago